Innovation in this space depends on strategizing for GMP compliance and market access.
Patrick Thiaville
Advertisement
Patrick Thiavilleis chief technology officer of Exothera.
Articles by Patrick Thiaville
Advertisement
Latest Updated Articles
Driving Innovation in Nucleic Acid TherapeuticsApril 1st 2024
Advertisement
Advertisement
Trending on BioPharm International
1
Sanofi Begins Construction of EU-Backed Insulin Plant in Frankfurt
2
Zylidac Bio to Scale Prolific's Optogenetic Cell Line Platform to GMP
3
TaiMed’s Anti-CD4 Antibody TMB-365 Reduces HIV Viral Load in Phase 1, Supporting Long-Acting Combination Regimens
4
Akeso's Ivonescimab Enters Phase 2/3 Biliary Tract Cancer Trial in US
5